Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.
Clinical trial NCT02470065 · SUSPENDED
Trial details
- NCT number
- NCT02470065
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2018-09-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.